Single-cell ATAC-seq exposes a critical twist in medulloblastoma’s story: after broad chromosomal hits spark tumor birth, late-emerging MYC-amplified subclones ignite aggressive progression—proof that tracking chromatin in real time can uncover the hidden drivers of relapse.